Author Login IJIRT Partner Network (IPN) Login

A VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF DESIDUSTAT IN PHARMACEUTICAL DOSAGE FORM

  • Unique Paper ID: 161587
  • Volume: 10
  • Issue: 5
  • PageNo: 142-147
  • Abstract:
  • An accurate, sensitive, precise, fast isocratic reverse phase HPLC (RP-HPLC) method has been developed and validated for the quantification of Desidustat in bulk and pharmaceutical tablet dosage forms. With acetonitrile as the organic solvent, the best separation was achieved on a 250 mmx 4.6 mm i.d., 5µ-particle size Inertsil®-Octadecyl-silyl-3V-Reverse-Phase-C18-column with 0.03M Potassium Dihydrogen Orthophasphate in water pH: 3.2 with Orthophosphoric acid: Acetonitrile (55:45) as the mobile phase solvent in the isocratic mode of elution at a speed of 0.8 ml.min−1. UV detection was at 246 nm. Retention time of Desidustat was 4.67 minutes. With a correlation coefficient of about 0.999, peak-response was obtained as a function of concentration over the range of 40 to 120 µg/ ml for Desidustat. Desidustat was shown to have a percentage assay of 98.6%. Desidustat had a limit of detection of 0.05 mcg/ ml and a limit of quantification (LOQ) of 0.15 mcg/ ml. The presence of excipients in the formulation had no effect on the assay method. The procedure is appropriate for use in QC- laboratories since it is economical and precise.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 10
  • Issue: 5
  • PageNo: 142-147

A VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF DESIDUSTAT IN PHARMACEUTICAL DOSAGE FORM

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry